Background and Purpose-Acute intracranial occlusion can be associated with in situ thrombo-occlusion in relation to preexisting intracranial atherosclerotic disease. We aimed to assess residual stenosis at the site of a target arterial lesion (TAL) to determine whether residual stenosis at the TAL is associated with underlying intracranial atherosclerotic disease. Methods-One hundred and sixty-three patients who underwent endovascular therapy for M1 middle cerebral artery occlusion and achieved angiographic reperfusion were selected for analysis. The presence of residual stenosis at the TAL was classified using the Arterial Occlusive Lesion (AOL) scale at postprocedural angiography, and the severity of stenosis was grouped into none, mild (<50%), moderate (50%-69%), severe (70%-99%), and occlusion on postprocedural and follow-up angiography. We also recorded the incidence of instant reocclusion occurring during the procedure and delayed reocclusion detected on follow-up angiography. Results-Seventy-four patients (45.5%) showed target arterial residual stenosis (AOL 2). As to the TAL pathogenesis, 40 patients were classified into in situ thrombo-occlusion (54.1% of AOL 2 and 24.5% of M1 occlusion). The occurrence of instant or delayed reocclusion was independently associated with a low chance of favorable 3-month outcome. Furthermore, the occurrence of delayed reocclusion was associated with excellent pretreatment collateral flow and early neurological worsening, but not the severity of residual stenosis at the TAL. Conclusions-In population with a high prevalence of intracranial atherosclerotic disease, residual stenosis may be attributed to in situ thrombo-occlusion with underlying intracranial atherosclerotic disease in ≈25% of cases, hindering functional recovery via the occurrence of instant or delayed reocclusion. 
I
n the newly established era of endovascular therapy (EVT) as a standard treatment for acute proximal vessel occlusive anterior circulation stroke, [1] [2] [3] [4] [5] the intrinsic pathology of a target arterial lesion (TAL) may be a major determinant toward the success of EVT and subsequent clinical outcome. 6 However, the pathogenic diagnosis of an acute intracranial occlusion using baseline imaging alone is often challenging, 7 as the occlusion may be caused by embolism from proximal or undetermined sources or by intrinsic arterial pathology.
Furthermore, in East Asia, there is a high prevalence of intracranial atherosclerotic disease (ICAD). 8 Acute intracranial occlusion can be considered as an in situ thromboocclusion (IST) in relation to preexisting ICAD at the site of occlusion, if there is any evidence of residual stenosis at the TAL subsequent to EVT or short-term follow-up angiography and no evidence of any definite proximal sources of embolism. 7, 9 To examine the presence of residual stenosis at the site of a TAL, the Arterial Occlusive Lesion (AOL) scale that measures the degree of recanalization (none, partial, or complete) may be used. 10 The presence of any degree of stenosis with distal flow at the site of a TAL denotes AOL grade 2, which may be a key indicator of underlying or intrinsic TAL pathology (eg, IST in relation to preexisting ICAD). However, one of the major issues in grading AOL hinges on the difficulty of distinguishing partial recanalization with a residual thrombus versus underlying stenosis or devicerelated vasospasm. 10 In the light of the above and the high prevalence of ICAD among Asians, we hypothesized that most instances of residual stenosis at a TAL may relate to IST with underlying ICAD. The aim of this study was to evaluate the baseline and followup characteristics of residual stenosis at the site of the TAL after EVT in relation to stroke pathogenesis, along with clinical and vascular outcome, to test this hypothesis.
Methods

Patients
Consecutive patients from a prospectively maintained acute stroke registry between May 2006 and December 2014 at our institution were retrospectively reviewed and selected. The inclusion criteria in this study were as follows: (1) EVT because of acute anterior circulation stroke with middle cerebral artery M1 occlusion, (2) sufficient angiographic reperfusion that was defined by a modified Treatment in Cerebral Ischemia (mTICI) grade of 2 to 3, 10 (3) evaluable angiographic imaging for the measurement of the stenosis at the TAL and grading of collateral flow, and (4) evaluable follow-up angiographic imaging (magnetic resonance angiography/computed tomographic angiography) acquired 5 to 7 days after EVT. Cases in which the cause of M1 occlusion was attributed to nonatheroslerotic conditions (eg, dissection, vasculitis, or moyamoya disease) were excluded from this analysis. The study protocol of retrospective analysis was approved by the local Institutional Review Board.
Endovascular Procedures
All selected patients underwent transfemoral cerebral angiography including injection into both carotid arteries and the dominant vertebral artery through the late venous phase under local or general anesthesia to determine the angioarchitecture of the occluded vessel and to assess collateral flow from all possible sources. Then, EVT targeting the middle cerebral artery M1 occlusion was initiated, and treatment strategies were selected on the basis of the available therapies at the time of angiography by the attending neurointerventionalist, which included intra-arterial thrombolytic (urokinase or recombinant tissue-type plasminogen activator) infusion, mechanical clot disruption, mechanical thrombectomy, including forced arterial suction thrombectomy or retrievable stent thrombectomy, rescue intraor extracranial stenting, or a combination of these approaches. [11] [12] [13] Adjuvant low-dose intra-arterial tirofiban infusion after reperfusion was used in the cases of reocclusion during the procedure.
14
Evaluation of Angiographic Images
All angiographic classification was evaluated by 2 independent raters (Y.W.K. and D.H.K.). Interobserver disagreement was resolved by consensus. The baseline grade of collateral flow was evaluated according to the American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology Collateral Flow Grading System on pretreatment angiography. As per this angiographic scale, collateral flow can be classified into grades 0 to 4 according to the completeness and rapidity of collateral filling in a retrograde fashion. 10 Recanalization and reperfusion status was measured using AOL and mTICI scales, 10 and if the TAL showed residual stenosis on final postprocedural angiography (AOL grade 2), the degree of stenosis was measured by the Warfarin-Aspirin Symptomatic Intracranial Disease Study (WASID) method. 15 The degree of stenosis was classified as mild (<50%), moderate (50%-69%), and severe (70%-99%). Furthermore, the degree of stenosis on follow-up (5-7 days) angiographic images were categorized as normal, mild (signal reduction <50%), moderate (signal reduction ≥50%), severe (focal signal loss with the presence of distal flow), and occlusion (sudden cutoff without distal flow void) using magnetic resonance angiography (n=151; 92.6%). 16 In patients who underwent computed tomographic angiography for follow-up angiographic imaging (n=12; 7.4%), the WASID method was applied to determine the degree of stenosis, and the presence of flow gap on computed tomographic angiography was defined as severe stenosis (with the presence of distal flow) or occlusion (without the presence of distal flow). The κ coefficient for interobserver agreement was 0.794 for each stenosis grading; specifically, 0.889 for ≥50% stenosis (moderate to occlusion) and 1.000 for occlusion. Moreover, occurrence of reocclusion during the procedure was recorded prospectively and defined as instant reocclusion (IR), whereas reocclusion detected on follow-up angiography was defined as delayed reocclusion (DR).
Pathogenic Stroke Classification
Stroke subtypes were operationally defined in this study to identify the pathogenesis of baseline TAL occlusion with reference to identifiable sources of embolism, the degree of stenosis at the TAL, as detected on the final postprocedural angiography and follow-up angiography, and concomitant stenosis (>50%) of the intracranial internal carotid artery, middle cerebral artery, vertebral artery, or basilar artery. The detailed flow chart of decision making is depicted in Figure 1 . 
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Clinical and Radiographic Evaluation
Information on demographic and clinical characteristics, vascular risk factors, and clinical outcomes were collected at baseline in prospective fashion. The onset of stroke was defined as the time when the patient was last observed to be normal. Stroke severity was assessed using the NIHSS at baseline and around 24-hour postprocedure. The diffusion-weighted imaging performed at baseline was assessed using the Alberta Stroke Program Early CT Score (ASPECTS). 17 All patients underwent a computed tomography or magnetic resonance imaging scan at 24 to 48 hours after the treatment. If there was evidence of hemorrhage, the subtype was classified as hemorrhagic infarction, parenchymal hematoma, subarachnoid hemorrhage, intraventricular hemorrhage, or mixed. 18 Symptomatic intracranial hemorrhage was defined as any type of hemorrhage associated with an increase in the NIHSS score of ≥4 within 24 hours. 19 Functional status was assessed using the modified Rankin Scale (mRS) score at 3 months, and a favorable outcome was defined as an mRS score of ≤2, or equal to the prestroke mRS score if the prestroke mRS was >2.
19,20
Statistical Analysis
Statistical analysis was performed using the SPSS statistical package (version 20.0, Chicago, IL). Statistical significance for intergroup differences was assessed by χ 2 test for categorical variables, Student t test for continuous variables, and the Mann-Whitney U test for ordinal variables and continuous variables that had skewed distributions. Multivariable regression analysis was performed to identify the factors that could be considered independent predictors of clinical and angiographic outcome. The results were presented as odds ratio estimates of relative risk with a 95% confidence interval. Probability values <0.05 were considered statistically significant.
Results
During the study period, a total of 163 patients were included for analysis, and the details of exclusion are described in Figure I in the online-only Data Supplement. On the basis of the presence of residual stenosis at the TAL on final postprocedural angiography, 74 patients (45.5%) were assigned to the TAL stenosis group (specifically, AOL grade 2), and 89 patients to the no-TAL stenosis group (AOL grade 3). The baseline characteristics, imaging, and clinical outcomes of the patients are described in the Table 1 . Compared with patients without residual stenosis at the TAL, those with the stenosis had a younger age at stroke onset, different profiles in vascular risk factors (higher prevalence of current smoker, and lower prevalence of atrial fibrillation) and pathogenic stroke subtypes (higher prevalence of IST), longer onset-to-puncture and EVT procedure times, and a higher incidence of reocclusion during EVT (IR) and follow-up angiography (DR), which were statistically significant.
A favorable clinical outcome at 3 months was observed in 107 of the 163 patients (65.6%) in our cohort. Furthermore, the rates of favorable outcome between patients with AOL grade 2 and AOL grade 3 did not differ significantly (60.8% versus 69.7%, P=0.236). On multivariable analysis, the presence of IR (odds ratio, 0.188; 95% confidence interval, 0.053-0.669; P=0.010) and DR (odds ratio, 0.035; 95% confidence interval, 0.005-0.243; P=0.001) was found to be independently associated with a lower chance of favorable outcome after adjustment for age at onset, baseline NIHSS score, and good or excellent baseline collateral flow (grade, 3-4; Table 2 ).
Characteristics in Relation to IST
Forty patients (24.5%) in the cohort were found to have IST as the presumed hidden pathogenesis of the TAL according to our newly devised definitions (Figure 1 ), and all of these patients showed target arterial residual stenosis at the final postprocedural angiography (40/74 [54.1%]). Furthermore, the severity of residual stenosis at the TAL was highly associated with the pathogenic stroke subtypes: specifically, IST was highly prevalent in patients with severe TAL stenosis among those with AOL grade 2 (30/37 [81.1%]; Figure 2A ). Compared with patients with non-IST pathogeneses, those with IST had a lower NIHSS score at baseline, higher prevalence of current smoker and excellent baseline collaterals, longer onset-to-puncture duration and EVT procedure time, and higher rate of IR and DR (Table 3) . With regard to the IST subgroup, favorable 3-month outcomes were observed in 2 of the 8 (25.0%) patients with DR and in 23 of the 32 (71.9%) patients without DR (P=0.014). The detailed descriptions of the cases with DRs are provided in Figure 3 , which shows the extension of the basal ganglionic ischemic lesion in most cases.
Factors Associated With IR and DR in AOL Grade 2 Subgroup
Overall, 20 patients (27.0%) revealed IR during the procedure in the AOL grade 2 subgroup (Table 1) . Acute management for IR during the procedure includes intra-arterial tirofiban infusion (15/20; 75%), rescue stenting (4/20; 20%), and repeated mechanical thrombectomy only (3/20; 15%). The detailed description of IR cases was shown in Table  I in the online-only Data Supplement. The rate of IR was much higher in patients with severe TAL stenosis (15/37; 40.5%) than in those with mild (2/17; 11.8%) or moderate (3/20; 15.0%) stenosis (P=0.032). Furthermore, the procedure time for EVT was considerably longer in cases with IR than in those without IR (P=0.000). The proportion of stenosis severity on follow-up angiography was diverse compared with the stenosis severity on postprocedural angiography (P=0.000; Figure 2B ). Also, 8 patients (10.8%) showed DR on follow-up in the AOL grade 2 subgroup (Table 1) . Furthermore, the rate of DR showed no intergroup difference in terms of stenosis severity (P=0.673; Table II in the online-only Data Supplement). The baseline variables that was related to DR were final mTICI 2a reperfusion, excellent baseline collateral flow, and any neurological worsening around 24-hour postprocedure (Table II in the online-only Data Supplement). On multivariable analysis, the presence of excellent baseline collateral flow and the presence of any neurological worsening was independently associated with a higher probability of DR after adjustment for the severity of residual stenosis at the TAL, EVT procedure time, and mTICI 2a reperfusion (Table 2) .
Discussion
In areas with a high prevalence of ICAD as a pathogenesis of stroke, the presence of intrinsic atherosclerosis can be problematic in terms of revascularization strategies. 14, 21 However, little is known about the incidence and interval changes of target arterial residual stenosis, its association with ICAD, and its impact on outcome. This study explored target arterial residual stenosis after EVT as a marker of IST, and its impact by guest on July 19, 2017 http://stroke.ahajournals.org/ Downloaded from on clinical and angiographic outcome in relation to ICAD. The novel findings of this study establish that: (1) the rate of residual stenosis at the TAL (AOL grade 2) was 45.5%; (2) IST as the underlying TAL pathology accounts for 24.5% of M1 occlusions and 54.1% of AOL grade 2; (3) the presence of IR and DR, which mostly occurred in IST pathogenesis, was independently associated with a lower chance of favorable clinical outcome; and (4) the occurrence of DR was highly associated with excellent baseline collateral flow and any early neurological worsening, rather than the severity of target arterial residual stenosis in the AOL grade 2 subgroup.
In general, the AOL scale, which measures the degree of arterial patency at the site of an occlusion after EVT, considered as a surrogate marker for clinical outcome. 10 However, the distinction between AOL grades 2 and 3 has drawn little attention in the clinical literature. The reasons for using both AOL grades 2 and 3 as a common denominator were as follows: (1) both AOL 2 and 3 recanalization were associated with good clinical outcomes 22 ; (2) the proportion of patients with AOL grade 2 among those with AOL grades 2 and 3 might has been insignificant in recent endovascular trials (eg, the rate of AOL 2 in the recent 23 In our cohort, the proportion of AOL grade 2 cases was ≈45%. In addition, more than half of AOL grade 2 cases and ≈25% of M1 occlusion cases were linked to ICAD as the underlying pathology. Recently, the pathogenic diagnosis of a TAL was explored based on different operational definitions, and ≈15% to 30% of intracranial occlusions were associated with underlying ICAD, which is in concordance with our results. 14, 21, 24 However, the definition of IST with underlying ICAD is still arbitrary, and most previous studies have adopted percent stenosis criteria to define the presence of ICAD. 21, 24 However, in our study, the main concept in classifying underlying TAL pathology was based on the interval changes between final postprocedural angiography and 5-to 7-day follow-up angiography to exclude residual stenosis because of procedure-related endothelial damage or a partially remaining thrombus (Figure 1) . Interestingly, ≈81% of the cases of severe stenosis and 27% of the cases of mild to moderate TAL stenosis were assigned to IST pathogenesis, which denotes the dynamic nature of target arterial residual stenosis during a short-term period.
As to the EVT, the presence of underlying ICAD can lead to a higher probability of IR, which might increase the procedure time.
14,25 However, its impact on clinical recovery is not yet clearly known. In our cohort, the occurrence of IR was closely associated with the IST pathogenesis, the severity of target arterial residual stenosis, and poor clinical recovery. Moreover, the occurrence of DR on follow-up magnetic resonance angiography/computed tomographic angiography was associated with IST pathogenesis and poor clinical recovery. Unlike IR, the severity of target arterial residual stenosis was unrelated to the occurrence of DR. Interestingly, the presence of excellent baseline collaterals, partial reperfusion (mTICI 2a), and any early neurological worsening was associated with the occurrence of DR, and after adjustment for mTICI 2a reperfusion, procedure time, and stenosis severity, the presence of excellent collaterals and any early neurological worsening remained as an independent predictor of DR. This finding can be novel, because it suggests that if a patient has well-developed collaterals at baseline, the chance of reocclusion during early postprocedural period can be high despite reperfusion. The reason for this phenomenon might be speculated as follows: (1) the preexisting excellent collaterals may preclude maintenance of reestablished antegrade perfusion; and (2) competing between antegrade and collateral flow may result in increased thrombogenicity at the site of a TAL because of slower flow. 26 Despite excellent baseline collaterals, DR resulted in the extension of basal ganglionic ischemic lesions, which might impede functional recovery. Also, any early neurological worsening as a predictor of DR was associated with minute rather than major changes in NIHSS score, which can be explained in virtue of preexisting excellent collaterals perhaps having a protective role in major neurological worsening. Furthermore, it might prevent clinicians to detect any clinical situations necessitating further rescue treatment for DR. Also, proposed management strategies were depicted in Figure II in the online-only Data Supplement.
This study has some limitations, and accordingly, the results need to be interpreted with caution. EVT in our cohort includes thrombolytic infusion and a variety of endovascular techniques. Therefore, the distinction between AOL grades 2 and 3 may be influenced by the device efficacy, and not only by the underlying ICAD, although the selection of EVT was based on the best available methods at the time of treatment. Furthermore, the exclusion of patients with failed reperfusion despite EVT and exclusion 
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of patients without follow-up angiographic images might under-or overestimate the actual proportion of patients with underlying ICAD. In addition, the definition of IST pathogenesis was based mainly on angiographic findings, and not on pathology. Furthermore, the interpretation of magnetic resonance angiographic data at follow-up has some limitations in relation to flow artifacts, which can overestimate the degree of stenosis despite a κ coefficient for interobserver agreement that was high enough for ≥50% stenosis and occlusion classification.
Conclusions
In summary, the novel findings of this study provide some insight into the relationships between target arterial residual stenosis, IST, instant or DR, and clinical recovery. These findings could be informative in designing EVT trials and performing EVT in populations with the highest prevalence of ICAD. However, further deliberations are required to establish criteria for the pathogenic diagnosis of IST and determine the best strategies to prevent instant or DR in this era of EVT.
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